etoposide has been researched along with fisetin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Honkakoski, P; Hytti, M; Kaarniranta, K; Kauppinen, A; Korhonen, E; Petrovski, G; Piippo, N; Szabó, D | 1 |
| Almeida, L; Coutinho, L; Fernandes, E; Ferreira de Oliveira, JMP; Oliveira, H; Pacheco, AR; Pinho, S; Santos, C | 1 |
3 other study(ies) available for etoposide and fisetin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Two dietary polyphenols, fisetin and luteolin, reduce inflammation but augment DNA damage-induced toxicity in human RPE cells.
Topics: Acetylation; Anti-Inflammatory Agents, Non-Steroidal; Cell Death; Cell Line; Cytokines; Dietary Supplements; DNA Damage; Etoposide; Flavonoids; Flavonols; Humans; Luteolin; Retinal Pigment Epithelium; Retinitis; Sirtuin 1; Tumor Suppressor Protein p53 | 2017 |
Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Cyclin E; Etoposide; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Oncogene Proteins; Osteosarcoma; Tumor Stem Cell Assay | 2018 |